An impressive variety of new methodologies for the preparation of 18 F-labelled tracers and ligands has appeared over the last decade. Most strategies of the newly developed radiofluorination methods predominantly aim at products of high molar activity by 'late-stage' labelling of small (hetero)aromatic molecules and the use of transition metals. This is accompanied by the improvement of technical procedures, like preparation of reactive [
Introduction
Given the very advantageous nuclear decay properties of fluorine-18, i.e. a half-life of 109.7 min and almost the smallest positron-emission energy of 635 keV maximum, ensuring a high imaging resolution, this radionuclide rapidly became the 'workhorse' of positron-emission tomography (PET) and has remained so now for more than 30 years. Especially, its favourable half-life allows, besides multi-step radiosyntheses, the supply of PET centres without a cyclotron by industrial production and the logistics of 18 F-labelled radiopharmaceuticals. This creates a concomitant desire for even better production of 18 F-labelled tracers and ligands. In fact, an impressive variety of new methodologies for radiofluorination has evolved over the last decade, extending considerably the possibilities of no-carrier-added (n.c.a.) radiosyntheses with fluorine-18.
A plethora of recent reviews already summarizes the major progress achieved, e.g. for the late-stage 18 F-fluorination of aromatic and heteroaromatic compounds [1, 2] , the use of prosthetic groups and building blocks [3] [4] [5] , asymmetric 18 F-fluorination [6] , bond formation of fluorine-18 with group 13 and 14 elements [7] [8] [9] [10] , as well as general and technical aspects [11, 12] . Since n.c.a. [ 18 F]fluoride is presently the most practical reagent to achieve 18 F-radiopharmaceuticals of high molar activity (A m ), the majority of labelling strategies are based on this initial reagent. Thus, special attention is given here to its isolation and activation in predominantly nucleophilic substitution reactions. Many of the described new labelling methodologies appear quite promising, like the silicon-fluoride acceptor labelling methodology or the application of organo- [ 18 F]trifluoroborates [9] . However, these inorganic 18 F-acceptors are still at an experimental stage, and difficulties in routine production hampered their widespread application. So far, only the [ 18 F]fluoroaluminium complex of an RGD peptide ([ 18 F]alfatide) has successfully been used in human clinical trials for PET imaging [13] . Regarding the clinical aspect, labelling by formation of Al-F [7] and Si-F [9] bonds therefore, is not considered here in more detail, although it has been examined for quite some time. Further on, the review only covers the radiosynthesis of mono-fluorinated compounds, and it does not address poly-fluorinated ones, like two-and tri-fluoromethylated derivatives, which were recently discussed in detail [1, 14] .
In this review, rather than the labelling of novel PET imaging probes, major newer radiosynthetic developments are regarded, which already have, or will probably have, an impact on the routine production on 18 F-radiopharmaceuticals, to meet the increasing clinical demands. This includes general basic methods of radiofluorination, the synthesis of established 18 F-labelled radiopharmaceuticals, as well as indispensable techniques for automation to enable their routine preparation and supply in high amounts of activity, using cassette kit systems and microfluidics. Besides efficiency, i.e. radiochemical yield (RCY), this rather concerns their suitability for practice, i.e. ease and reliability of routine application. Furthermore, the procedures have to fulfil the criteria of radiopharmaceutical production under conditions of good manufacturing practice (GMP) [15] . A comparative evaluation will require including all those aspects. However, a comparison of different reports is often hampered, since uniform definitions for the RCY as for other technical terms and units [16] are missing. In addition, RCYs are often only analytically determined from small samples of the reaction solution, and refer to a single conversion step of build-up syntheses only. Thus, for an objective comparison of different methods, only the RCY of the final isolated radiotracer is meaningful reflecting the whole production process.
Two special criteria of the synthesis of radiopharmaceuticals labelled with fluorine-18 have principally to be considered. Their use requires high amounts of starting activity, due to its rather rapid decay. Therefore, labelling can only be performed by synthesis devices, which are placed in shielded "hot cells". In addition, simple synthetic procedures with as few reaction steps as possible are required, allowing their straightforward, remote-controlled implementation, and execution. The other aspect concerns the fulfilment of the GMP regulatory, i.e. production processes must comply with the requirements that will assure product quality, patient safety, traceability of the process, and reliability and robustness of the performance. Along with the introduction of more efficient and flexible 18 F-labelling methods, also many novel technological approaches emerged. Consequently, concepts of reliable 18 F-labelling techniques, amenable to automation on synthesis modules as well as fulfilling GMP requirements, have to be realised as major prerequisites of the routine production of 18 F-labelled radiopharmaceuticals for PET imaging.
Electrophilic

18
F-fluorination
Due to the technological simplicity of labelling with elemental [ 18 F]fluorine gas, which is directly usable as received from the target, electrophilic 18 F-fluorination was earlier the method of choice for the routine production of especially electron-rich, ring-labelled aromatic [ [17] . However, since only a low A m of ca. 100 MBq/µmol was obtainable by this procedure, it was limited to non-toxic compounds, which still achieve the criteria of the tracer principle, when administered in micromole (up to ca. 0.5 mg) amounts, as shown for labelled fatty acids, amino acids, or sugars.
Given the gaseous fluorination reagent [ 18 [31] . A broader application of this approach in a clinical setting, however, remains questionable, considering the above properties and its exclusion for synthesising 18 F-ligands, which require generally a high A m .
In early radiofluorination studies, elemental fluorine-18 was technically the easiest to obtain, and consequently, unsaturated hydrocarbons were used for the preparation of radiofluorinated alkanes and alkenes [32, 33] . However, besides the disadvantages already described above for electrophilic radiofluorination of arenes, the formation of neither enantioselective nor position-selective products became an Thus, the main technical restrictions of electrophilic methods are besides the limited amounts of activity, which can be produced cost-effectively, the constraint of the achievable A m , even with the approach via n.c.a. [ 18 F]CH 3 F, and the need of special target equipment, withstanding the use of corrosive F 2 gas. In a clinical setting, therefore, methods using electrophilic reagents are only rarely used today. 
Nucleophilic
18
F-fluorination
F]fluoride for nucleophilic substitution
Even more than under 'macroscopic' conditions, so-called 'naked' fluoride is desirable, to ensure its high nucleophilic reactivity under no-carrier-added conditions. This is optimally achieved in the form of a weak ion pair (salt or complex) of n.c.a. [
18 F]fluoride with soft cations in preferably aprotic solvents. It must be kept in mind that fluoride in this state exhibits also a very high basicity. Thus, to obtain such conditions, it is mandatory that there is no chance of complexation with 'hard' Lewis acids, especially protons or small cations, forming tight ion pairs, strong hydrogen bonds or even hydrogen [ 18 F]fluoride, respectively. The readily polarizable cations of the above-mentioned phase-transfer catalysts, i.e. cryptand or tetraalkylammonium salts, together with basic, non-nucleophilic anions (e.g. CO 3 2− or HCO 3 − ) in dipolar, aprotic solvents, fulfil the requirements rather ideally and have widely become the standard conditions for nucleophilic radiofluorination [25, 46, 47] .
With highly reactive precursors, however, caesium and rubidium carbonates are already sufficient to achieve nucleophilic radiofluorination on an n.c.a. level [48] . As further discussed below, newer studies even proved that the presence of phase-transfer catalysts can be avoided using the ability of special labelling precursors to induce activation of [ 18 F]fluoride. In one case, arylsulfonates, as aliphatic leaving groups carry polyether moieties, which take the function of chelating the cation [49] . Another, a "minimalist" approach takes advantage of aromatic precursors, which are onium compounds, like iodonium and ammonium (not yet sulfonium) salts, playing the role of soft cations themselves [50, 51] . Surprisingly, it turned out during the last 10 years or so that nucleophilic substitution with n.c.a. [ 18 F]fluoride proceeds occasionally better in mixtures of acetonitrile and
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tert-butanol as solvents [52] . Here, obviously, the interaction of [ 18 F]fluoride in those "protic" solutions with hydrogen is weak enough to fulfil the above-mentioned criteria. In part, this can be attributed to the higher basicity of tertbutanolate, for example, than of fluoride, but a beneficiary supporting effect of those solvent mixtures on the nucleofugality of leaving groups was also discussed [53] . Furthermore, to an increasing degree, there are studies, demonstrating that even in the presence of traces of water effective nucleophilic exchange with n.c.a. [ 18 F]fluoride occurs, as shown with various examples below. Indeed, weak interaction with hydrogen (cages) can even replace other soft cations for nucleophilic activation of fluoride of increased selectivity as recently systematically examined with the stable isotope [54] . All of these latter findings will potentially expand the radiofluorination possibilities tremendously and also offer potential for considerable facilitation of quality control procedures, when compared with the former methods, where the more difficult to analyse aliphatic phasetransfer catalysts were used for activation of 18 O]water, and then eluted with a solution of potassium carbonate and the activating cryptand or a tetraalkylammonium salt. The following drying is performed azeotropically using acetonitrile. Today, this time-consuming and multi-step procedure is established in most commercial synthesizers [45, 55] .
Multiple methods were examined over the years to optimize this procedure, especially simplifying it. The implementation on a microchip device necessitates a concentration of the [ 18 F]fluoride production are between 0.7 and 7 mL which are mostly reduced to a volume of < 500 µL for this purpose [56, 57] . Thus, the thermal evaporation step is far from convenient for an application in a microscale device.
Another aspect is the use of a base for eluting the [ F-fluorination reaction. To minimize the amount of the base, alternative anions of low basicity like potassium phosphate, potassium mesylate, and potassium triflate, or in the case of copper-mediated 18 F-fluorination, the use of 4-di-methylaminopyridine was successfully applied for the elution of [ 18 F]fluoride from an anion-exchange cartridge [58] [59] [60] . A methanolic instead of an aqueous solution of crypt-222/K 2 CO 3 reduced significantly the time of the subsequent thermal evaporation [59, 61] . Methanol as solvent for [ 18 F]fluoride elution was also applied in the already mentioned efficient and time-saving "minimalist" approach [50] . The smart idea behind this is the use of onium compounds as precursors for labelling, serving itself as cation without addition of a phase-transfer catalyst to obtain highly reactive n.c.a. fluoride. After washing the 18 F-loaded anion-exchange cartridge with dry methanol for removing water, [ 18 F]fluoride is eluted in this case together with the onium precursor dissolved in methanol. This is subsequently evaporated, and a desired organic solvent is added to the dry mixture to perform the nucleophilic exchange reaction. [62] . However, an enormous improvement could be made using phosphazene bases fixed on a polymer support, which allowed nearly quantitative trapping and drying of [
18 F]fluoride with dry organic solvents and subsequent radiofluorination on the solid phase [63] .
An interesting alternative to the radiofluorination on a solid phase without a need of azeotropic drying is the use of titanium oxide nanoparticles. Here, the labelling precursor, containing a tosylate leaving group, is pre-incubated with TiO 2 nanoparticles in an acetonitrile/hexyl alcohol mixture and tetra-n-butylammonium bicarbonate for anion activation, and then, it is directly reacted with [
18 F]fluoride in [
18 O]H 2 O. This rapid and efficient nucleophilic reaction tolerates a water content of up to 25 vol%, and 18 F-fluorination of several aliphatic and even aromatic compounds was successfully performed without a drying step, using the corresponding tosylated precursors [64] .
In contrast, to perform the drying process of [ 18 F]fluoride on an anion-exchange cartridge, it is required to find an eluting system which does not necessitate the addition of water. In fact, the classical approach, using the crypt-222/K 2 CO 3 system, proved unsuccessful for this purpose. Applying an anhydrous solution of crypt-222/KOH in CH 3 [67] . This method, however, appears technologically rather demanding for automation.
Phosphazene bases, especially 1-tert-octyl-4,4,4-tris(dimethylamino)-2,2-bis-[tris(di-methylamino) phosphoranylidenamino]-2λ5,4λ5-catenadi(phosphazene) (P 4 tBu), if dissolved in acetonitrile, can also be used for elution of [ 18 F]fluoride from an anion-exchange cartridge [68] . Water, added into the strong base, is converted to the hydroxide anion, which leads to the replacement of [ 18 F]fluoride on the cartridge. Residual water on the cartridge will also be converted, and thus, it does not disturb the subsequent 18 F-reaction. However, the strong basicity of the solution rather limits its application, especially with base-sensitive precursors. In another report, when water was not completely absent upon elution, it was successfully removed by rinsing the eluate of [ 18 F]fluoride over a cartridge containing Na 2 SO 4 as drying agent [69] . However, in the following studies, it was shown again that a certain amount of water does not always disturb a nucleophilic n.c.a. 18 F-substitution reaction. In another approach, [ 18 F]fluoride was trapped on a solid phase of water-wettable macroporous copolymer coated with a quaternary long chain alkylammonium carbonate. After purging the cartridge with nitrogen gas, the [ 18 F]fluoride was eluted with acetonitrile. The received solution proved directly useful for nucleophilic aliphatic and aromatic 18 F-fluorination reactions without further azeotropic drying [70] . A further study made use of tetraethylammonium hydrogen carbonate, dissolved in a dipolar aprotic solvent, like acetonitrile, DMSO or DMF, with a content of 5% water, enabling the quantitative elution of [ 18 F]fluoride from an anion-exchange cartridge. This solution was also suitable for performing the 18 F-fluorination of several aliphatic and aromatic compounds, tolerating a low amount of water [71] .
In addition, ionic liquids enabled the n.c.a. 18 F-substitution reaction on aliphatic compounds in the presence of water. However, a severe disadvantage of this approach is the high viscosity of these solvents, hindering its wider application [72] . Another drying method with a cartridge used the sequence of flushing it with air and then removing residual water with anhydrous acetonitrile. Upon elution with a combination of a cryptate, a potassium salt and an appropriate solvent containing 1% water, [ 18 F]fluoride could directly be employed for the labelling reaction. This procedure was also successfully integrated into a "lab-on-chip" synthesis platform [73] .
Quite recently, it turned out in case of the important 18 F-fluoroethylation reaction that [ 18 F]fluoride eluted from an anion-exchange column formed the desired labelling agent 2-[
18 F]fluoroethyl tosylate in up to 96% RCY, which was directly ready for further coupling reactions. Here, the K 2 CO 3 /crypt-222/acetonitrile solution, containing 2-3% (v/v) water, was directly given to the 1,2-ethylene glycolbis-tosylate precursor. When compared to the conventional approach, this so-called "hydrous 18 F-fluoroethylation" seems very promising. It improved considerably the radiochemical yield of isolated radiotracers by shortened overall reaction times and minimum loss of [ 18 F]fluoride [74] . In general, nucleophilic aromatic 18 F-substitution reactions are sensitive to moisture. However, it could again be shown that in special cases the reaction is tolerant to water. For example, some diaryliodonium tosylates, XArI + Ar'Y TsO − (X = H or p-MeO), could be converted to the desired [ 18 F]fluoroarene in moderate radiochemical yields notwithstanding a water content of up to 28% [75] . A further special case was demonstrated with the use of rhenium(I) complexes of 2-chloro-1,10-phenanthroline for radiofluorination. With Re-complexes present, it surprisingly proved to be tolerant to some content of water, while the 18 F-fluorination with nonRe-complexed 2-chloro-1,10-phenanthroline could only be performed in absence of water [76] .
Very benefitting, the novel Cu-mediated 18 F-fluorination methods, using (hetero)-arylboronic acids, pinacolyl boronates, or trialkylstannanes as precursors, enabled the rapid 18 F-fluorination without azeotropic drying steps when using alcohols as co-solvents. This technique allowed "late-stage" 18 F-fluorination of indoles, phenols, and anilines starting from unprotected precursors, and led to a RCY in the range of 80-99% for many radiofluorinated aromatic compounds [77] .
Separation of [
F]fluoride via electrochemistry
In principal, a very elegant method to isolate and concentrate n.c.a. [ O]water, would be its anodic deposition and release. This technology would also offer and facilitate possibilities of online integration with micro synthesis devices, e.g. lab chips, microfluidics etc., for subsequent n.c.a. nucleophilic 18 F-fluorination. Based on previous experiences, an electrochemical cell was already designed, allowing to recover the deposited [ 18 F]fluoride in the presence of an aprotic solvent, containing a phase-transfer catalyst. The radionuclide, electro-chemically adsorbed at the cylindrical surface of a glassy carbon electrode, could easily be dried by washing the cell with dry aprotic solvents while maintaining a low electric field, which made an azeotropic drying process obsolete [78] .
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To optimize the release of n.c.a. [ 18 F]fluoride from the electrode, various structural modifications of carbon anodes, ranging from thin layers of crystalline boron-doped diamond up to highly graphitic bulk materials, were systematically examined. From those, pyrolysed carbon, i.e. "glassy carbon" (Sigradur ® G), proved the most effective material for deposition and release, providing an overall radiochemical yield of about 60% for fixation and release of [ 18 F]fluoride into DMSO/ionic additive as organic solution [79] .
A further approach employed brass-platinum as electrodes, which proved the best material from a range of metals in an electrochemical micro-flow cell, to extract [ 18 F]fluoride from water and to release it into an organic solution in a fast and reliable manner. This cell proved not to suffer electrode erosion, to be reusable, and enabling application of increased voltages, so that it could be operated faster. Optimizing temperature, trapping and release potentials, flow rates, and electrode materials, an overall trapping and release efficiency of about 85% was achieved [80] .
In addition, using brass as anode material, the electrochemical method was already earlier realized for a microfluidic radiosynthesis by concentrating and transferring n.c.a. ]fluoride ready for subsequent microfluidic radiosynthesis, claiming an overall radiochemical yield of 60% for its isolation, albeit with a bigger volume of accompanying solvent [81] . 18 
Progress in aliphatic nucleophilic
F-fluorination
Aliphatic nucleophilic 18 F-fluorination is today the most frequently employed method for routine production of radiopharmaceuticals, because the majority of those are 18 Fig. 1 ). Newer improvements in the reliable preparation of the latter two are briefly summarized here. The methods for radiosyntheses can generally be divided into direct methods, i.e. "late-stage" 18 F-fluorination, or in indirect methods via 18 F-labelled building blocks [3, 5] .
[ F-fluorination of 1,2-bis(tosyloxy)ethane, with the sodium salt of tyrosine [82] . This procedure was optimized with regard to purification and automation [83, 84] . Alternatively, an improved one-pot procedure, starting from a protected tyrosine derivative and thus allowing direct substitution, simplified the automation process [85] and was also further considerably optimized [86] .
F]FET
An improved yield of [ 18 F]FET was achieved by another direct nucleophilic synthesis, using an earlier developed chiral precursor, i.e. the Ni(II) complex of an alkylated (S)-tyrosine Schiff base, Ni-(S)-BPB-(S)-Tyr-OCH 2 -CH 2 OTs. A solid-phase extraction for purification omitted a cumbersome high-performance liquid chromatography (HPLC) purification, when using a combination of reverse phase and strong cation-exchange cartridges for solid-phase extraction. The method was successfully automated on a commercially available synthesis module, and it provided [ 18 F]FET in high chemical, radiochemical, and chiral purity and in 35% radiochemical yield within 45 min of synthesis time [87] .
In addition, a resin-linker-vector strategy was recently described for 18 F-labelling of such tracer molecules, which releases the labelled vector from the solid phase into solution upon nucleophilic substitution of a polystyrene-bound arylsulfonate leaving group with the [ 18 F]fluoride ion [88] . In such cases, the efforts of synthesis and quality assurance for the solid-linked precursor must be taken into consideration.
18 F]fluoro-L-thymidine is an established PET tracer applied to study cell-proliferation rates in tumours [89] . The original syntheses are characterised by low activity yield and uncertain, time-consuming HPLC purification [90, 91] , which were the main obstacles for routine clinical use of [ 18 F]FLT [92, 93] . To alleviate these difficulties several improvements were made for the synthesis of [ [94-100]. The best RCY was received, using 5′-O-(4,4′-dimethoxytriphenylmethyl)-2,3′-anhydrothymidine (DMTThy) as labelling precursor [98, 99, [101] [102] [103] . Yet, another publication reports on a reliable, simple, and efficient preparation of [ 18 F]FLT, which provides an ethanol-free solution of the tracer without need for any HPLC purification. Due to the similarity with the [
18 F]FDG synthesis, the method can principally be implemented on all commercial modules available for this common radiotracer [104] . Correspondingly, a further report also describes a high-yielding, automated production of this tracer, using a modified [ 18 F]FDG reaction module [105] . And last, not least, [ 18 F]FLT was also synthesized with a remarkably improved radiochemical yield (85 ± 4% analytically and 60 ± 5% upon automated production) by nucleophilic substitution when catalysed by a protic solvent under mild reaction conditions in a short preparation time [106] . This seems to be a very attractive method.
General improvements
Besides the newer developments concerning the routine production of established radiopharmaceuticals, general improvements of aliphatic radiofluorination with high potential for a broad application in PET imaging are also to be mentioned. A recent publication summarises various newer nucleophilic methods, employing transition-metal complexes or organocatalysis for asymmetric 18 F-fluorination of alkanes, thus widely overcoming the problems of regioselectivity and enantioselectivity encountered with addition reactions of elemental fluorine-18 [6] .
Another promising development of aliphatic 18 F-labelling makes use of arylsulfonate as nucleophile assisting leaving groups (NALGs). There, a metal chelating unit is attached to the aryl ring by an ether linker. A series of NALGs prepared exhibited significant rate enhancements in halogenation reactions, using metal halides. Studies with an NALG, containing a macrocyclic ether unit, suggest that rate enhancements of these nucleophilic halogenation reactions are facilitated by a stabilization of charge in the transition state rather than through strong pre-complexation with the metal cation [49] .
Remarkable novel developments enable even the direct 18 F-fluorination on non-activated aliphatic C-H bonds, using a manganese porphyrin/iodosylbenzene system with n.c.a. [ 18 F]fluoride (see Scheme 1) [107] , and furthermore, a higher selectivity favouring substitution versus elimination was achieved by organocatalysis through hydrogen bonding of fluoride; however, so far, only demonstrated on the carrier-added level [54] . These new approaches hold very great promise as powerful alternatives for aliphatic 18 F-fluorination in the future. 18 
Progress in aromatic nucleophilic
F-fluorination
The first pathway to introduce n.c.a. [
18 F]fluoride into arenes for routine synthesis of radiopharmaceuticals was the classical S N Ar method. Since it necessitates the presence of a leaving group and an electron-withdrawing group, preferably in ortho-or para-position, this approach was completely limited to electron deficient arenes [1, 11, 12, 25 , 26], exhibiting a major challenge [108] .
The first molecule that was 18 F-labelled via this approach for clinical application and is in use still today [109, 110] has been the serotonergic 5-HT 2A receptor ligand [ 18 F]altanserin [111, 112] . Like in many other complex molecules Scheme 1 18 F-Fluorination of non-activated C-H bonds exemplified for Boc-protected 1-amino-cyclopentanecarboxylic acid methyl ester; adapted from [107] with activated carbocyclic aromatic positions [113] , the keto group in para-position activates the 18 F-for-NO 2 exchange employed here, and the one-step synthesis is performed without the need of a protecting group. However, the reaction leads to a side product, which necessitates an extensive HPLC purification [114] .
The same classical S N Ar strategy was used for the synthesis of 4- (2′-methoxyphenyl)-1-[2′-(N-2″-pyridinyl) [119] , were also efficiently 18 F-labelled via the S N Ar method, notwithstanding that the activating and leaving groups are in weaker activated meta-position of the benzene ring, which necessitates harsher labelling conditions (see Fig. 2 ).
An S N Ar reaction can of course directly be performed on sites of heteroarenes as in the ortho-position of pyridine or 2-positon of 1,3-thiazoles, which are activated for an 18 F-for-X exchange (X = NO 2 Fig. 2 ) [126, 127] . In addition, small radiofluorinated heteroarenes proved very useful as prosthetic groups for labelling of macromolecules, such as proteins and oligonucleotides [121] .
During the last decade, three strategies were established for 18 F-fluorination of non-activated or even electron-rich arenes, the most challenging compounds for nucleophilic substitution with n.c.a. [ 18 F]fluoride [108] . Three methodologies were elaborated for nucleophilic 18 F-synthesis of these kinds of compounds and have the ability to replace the electrophilic 18 F-fluorination of electron-rich arenes. These are: (i) three-step reactions, consisting of an 18 F-displacement reaction, removal of an activating group and hydrolysis of protecting groups, and one-or two-step reactions, (ii) employing"onium" compounds as precursors and most recently (iii) by transition-metal-mediated radiofluorination. In most cases of the latter two methods, the radiofluorination step is again followed by hydrolysis of protection groups.
Formerly, for radiofluorination of non-activated arenes methods via build-up syntheses, using 18 [129, 130] . This approach was improved over a long period [131] and is now established in commercially available synthesis devices [132] .
An alternative carbonyl-activated, three-step 18 F-fluorination was realized for the syntheses of the aromatic 18 Fig. 3 ). Here, the 18 F-displacement reaction is activated by a carbonyl function in ortho-or para-position, which is subsequently transformed either by Baeyer-Villiger oxidation to a hydroxyl group, or completely removed using the Wilkinson catalyst. This concept offers the possibility of a one-pot synthesis, as was established, for example, in a synthesis device with a modified precursor for the synthesis of n.c.a. 6-[
18 F]FDOPA [136] . On the other hand, this procedure is sensitive to the basic conditions of the 18 F-fluorination reaction, which can lead to an epimerization of the amino acid.
In a recently published study on the nucleophilic synthesis of 6-[
18 F]FDOPA both methods of carbonyl-activated 18 F-exchange were compared, using the 3-and 5-step procedure [137] . It was convincingly shown that the three-step process was much easier and reliable to be automated, providing an RCY of 20 ± 1% within 114 min.
The iodonium strategy (method ii), which was for the first time introduced into 18 F-radiochemistry in 1995 [108, 138, 139] , like the use of triarylsulfonium salts [140] , was initially limited to the synthesis of small molecules, like [142, 143] . The latter served especially as building blocks in transition-metal-mediated reactions for the synthesis of 18 F-radiotracers [128, 144] . This type of reaction has been well established in commercially available synthesis devices [145] . For the last decade, then the challenges for late-stage 18 F-fluorination of complex molecules, using iodonium compounds, were solved more and more, and a new review extensively discusses in detail their utility for small molecules, including mechanistic as well as application aspects [142] .
Improvements included novel methods for the synthesis of iodonium salts [146] , like methoxyaryl [147] [148] [149] or arylthienyl [150] precursors, the introduction of iodonium ylides [151] [152] [153] , and the use of mesitylaryliodonium salts for a copper-mediated 18 F-fluorination [154] (see Fig. 4 ). The limited use of mesitylaryliodonium salts of electronrich arenes, which is due to their poor long-term stability, was overcome by the in situ formation of these iodonium salts during the nucleophilic 18 F-fluorination [155] . The use of iodonium ylides enabled an efficient and automated synthesis of 3-[ [156] . Combining iodonium precursors with the above-mentioned "minimalist" method, the Cu-mediated nucleophilic radiofluorination enabled the direct introduction of [ 18 F]fluoride into electron-rich arenes with very high radiochemical yields and its implementation on a commercially available synthesis module [51, 157] . In addition, two studies describe a reliable automated GMP production of the radioligands [
18 F]flumazenil and [ 18 F]UCB from iodonium salts with a RCY of about 55 and 35%, respectively [158, 159] .
Besides the use of "onium" salt moieties as leaving group, phenols and anilines can also act as such, but they have to be pre-modified. The 18 F-deoxyfluorination of phenols became feasible by a transition-metal assistance, as recently reported for the first time [160] . This ruthenium-mediated reaction will probably offer a valuable addition to radiofluorination techniques. The transformation was claimed to benefit, besides the readily available phenols as starting materials, from tolerance of moisture and ambient atmosphere, accessing a large scope of compounds, and proved the ability to generate activity doses of products, like for [ 18 F]bavarostat, appropriate for PET imaging [161] . The nucleophilic radiofluorination of anilines with [
18 F]fluoride was achieved by the initial modification of ArNH 2 to an N-arylsydnone precursor via a two-step process. However, the N-arylsydnone is only replaced by [ 18 F]fluoride, when activated by an electron-withdrawing group (see Scheme 2) [162] .
The novel transition-metal-mediated 18 F-labelling strategies (method iii) have a major potential to revolutionize 18 F-labelling of even electron-rich arenes. Operationally simple under relatively mild reaction conditions, they can be performed at the n.c.a. level, the required precursors are mostly stable at room temperature, and they can be applied to a wide range of compounds (see Fig. 5 ).
The first attempts were performed by palladium-mediated radiofluorination [163] of Pd(V) complexes as precursors [164] , or by nickel-catalysed 18 F-reactions [165-167] (see Fig. 5 ). However, those first attempts did not fulfil the desired, afore mentioned properties. The breakthrough was the introduction of copper-mediated 18 F-displacement reactions, using arylboron [168, 169] and arylstannanes [170] as precursors. The latter ones, which were earlier synthesised for electrophilic 18 F-fluorination, offer here a convenient possibility to use these precursors also for the copper-mediated nucleophilic substitution, as shown for the syntheses of [ [176] . So far, however, the process of adapting these new transition-metal assisted reactions for automated production of radiopharmaceuticals has revealed limitations in fitting them into the confines of traditional radiochemistry systems. In particular, the presence of bases (e.g. K 2 CO 3 ) and/or phase-transfer catalysts (e.g. crypt-222) associated with 18 F-preparation was even found to be detrimental here to reaction yields. These limitations could be addressed by the development of alternative techniques for isolation F-fluorination using N-arylsydnones (R = electron-withdrawing group) [162] of [ 18 F]fluoride from the target, providing the possibility to tailor an eluent individually which meets the specific needs of a metal-catalysed reaction of interest. It was demonstrated that various solutions of copper salts, bases, and ancillary ligands can be utilized for these reactions to elute In the case of the Cu-mediated 18 F-labelling, even a beneficial effect of primary and secondary alcohols was reported. This observation contradicts the earlier assumption that such alcohols are inappropriate solvents for aromatic fluorination (see discussion above). Indeed, a protocol has been developed for rapid radiolabelling of an extraordinary broad scope of boronic esters and stannylated precursors, and radiofluorinated indoles, phenols, and anilines were synthesized directly from the corresponding, unprotected precursors [77] . This novel method enabled the facilitated preparation of [ 18 [178] .
Especially, 6-[ 18 F]FDOPA exhibits a great importance in PET imaging for more than 30 years with the focus on neurological diseases [179] and later on of neuroendocrine tumours [180] . As mentioned, many methods have been developed, using electrophilic as well as nucleophilic approaches [21, 181, 182] , to improve the synthesis of 6-[
18 F]FDOPA. These are summarized in Table 1 for comparison and to exemplify the tremendous efforts invested to optimally meet routine clinical supply of a radiopharmaceutical. 18 
Electro-chemically supported
F-labelling
Based on the previous experiences with anodic deposition of no-carrier-added [ [112] .
Furthermore, the electrochemical method proved ability to label aromatic rings through direct nucleophilic 18 F-fluorination of cationic intermediates. At first, this was successfully shown for the carrier-added synthesis of a [ 18 F]fluoro-phenylalanine derivative using galvanostatic conditions [185] . Also, a direct nucleophilic radiosynthesis of di-tert-butyl-(4-[
18 F]fluoro-1,2-phenylene)-dicarbonate was achieved by a no-carrier-added electrochemical reaction under potentiostatic conditions, using di-tert-butyl-(4-(tertbutyl)-1,2-phenylene)dicarbonate as precursor, however, with less than 2% radiochemical yield only. In this case, a 10 mM solution of triethylamonium acetate (Et 3 NAc) in acetonitrile was used to release the [ 18 F]fluoride ions trapped on a quaternary ammonium anion-exchange resin [186, 187] . Automation of nucleophilic 18 
F-fluorination
The automation of 18 F-syntheses is an indispensable prerequisite for clinical application of PET tracers. It enables fast and reliable syntheses, the use of high amounts of radioactivity, and it simplifies the fulfilment of regulatory compliances (GMP requirements), including the sterility of the radiopharmaceuticals routinely prepared [189, 190] . Many principally different automated synthesis modules and platforms have been designed and implemented to produce 18 F-probes in an efficient, reproducible and safe manner, which allow carrying out repetitive synthetic steps and production cycles, and which are commercially available [191] for electrophilic and nucleophilic 18 F-fluorination reactions [20, 45] . However, as discussed above, the nucleophilic approach is by far the dominating method for the synthesis of 18 F-labelled radiotracers and radioligands. Novel nucleophilic radiofluorination methods have the potential to replace all electrophilic methods, aiming to achieve n.c.a products and to minimise the chemical burden to patients.
The first commercial available synthesis devices were designed for the implementation of the [
18 F]FDG synthesis, which only required the use of one reactor, where the radiofluorination step and the hydrolysis step was performed [44, 62, 192, 193] . The subsequent purification procedure was performed by solid-phase extraction, leading to a high quality of the final product. However, other nucleophilic 18 F-labelling pathways often necessitate the use of a tworeactor system and/or HPLC purification after labelling and deprotection. Most of the commercial available automated devices are stationary, fixed-tubing systems. There, purification has to be performed after each run, and the hardware (tube, valves, plumbing) cannot be exchanged in day-to-day operation.
Alternatively, to get more flexible systems, modular subunit systems were developed [194] . As an example, a plugand-play radiosynthesis platform accompanied by computer software based on modular subunits can easily and flexibly be configured to implement a diverse range of radiosynthesis protocols [194] . Using such systems, the standard procedures ( 18 F-labelling, hydrolysis and purification) have been implemented for many clinically relevant 18 F-tracers [103, 105, 191, [195] [196] [197] or 18 F-labelled building blocks RCY 54 ± 5% [177] for labelling of macromolecules [198] [199] [200] and build-up syntheses [145] . A special type of synthesis device is the hardware kit system, also called "cassette system" [201] . All reagents, which are needed thereby for radiofluorination, are prefabricated and enclosed in disposable cassettes, which are easily switched on the synthesis device. This enables multiple runs of 18 F-syntheses in short intervals on the same production day, because the exhausted and contaminated cassettes can quickly be removed into lead shielded waste boxes. Furthermore, these cassette systems reduce the time and effort of validation and cleaning processes, and thereby the risk of cross-contamination, what again facilitates the fulfilment of the GMP requirements. Thus, the implementation of a radiofluorination process into a cassette system is the aim of many new developments. However, a drawback of these kit systems might be high costs and possible difficulties with the supply of hardware kits.
In an early stage of an automation process, however, conventional fixed-tubing systems offer more flexibility for establishing an 18 F-fluorination process. As alternative, therefore, a novel fully automated 3-reactor radiosynthesiser was developed, which combines the advantages of both systems [202] .
Several radiotracers have been implemented on standard synthesis devices fulfilling the GMP requirements for clinical trials as mentioned above for [ 18 
Microfluidic technology
Microfluidic devices appear as an attractive technology for the preparation of labelled radiotracers. The extremely low amounts of n.c.a. [ 18 F]fluoride offer the possibility to improve the efficiency of radiolabelling, using microfluidics [56, [209] [210] [211] [212] [213] [214] . Compared to the "vessel" chemistry, where the radiofluorination is performed in vials of 5-20 mL size, the volume of microfluidics "vessels" are on the microliter scale. Therefore, the amount of chemicals, especially of rather expensive labelling precursors, can be tremendously reduced. This also leads to an improvement of the A m , minimizing the contamination by the non-radioactive isotope [212] , and the reaction time can significantly be shortened [215] . The microfluidic approach offers the implementation of a single-use system, enabling a dose-on-demand approach, which provides the synthesis of the desired radiotracer in proximity to the PET scanner [210] .
Several challenges can be defined for the implementation of microfluidic technology in 18 F-chemistry, which are partly solved today. The whole process, including the pre-concentration of [ 18 F]fluoride, the synthesis steps (radiofluorination and deprotection), and the purification and formulation of the final product have to be miniaturized.
In this context, the concentration of [ 18 F]fluoride from millilitre target volumes to microliter reaction volumes is of great importance. Several concepts were studied to minimize the volume obtained from target (compare above). The common one is the use of anion-exchange cartridges with low internal volume to reduce the complete volume of the eluate [57, 216, 217] . The usefulness of electrochemical methods for the concentration of [ 18 F]fluoride suitable for microfluidic devices was successfully demonstrated by nucleophilic 18 F-substitution of several radiotracers [80, 218] . In a novel development [ 18 F]fluoride is captured on QMA-tagged magnetic particles in a solution and subsequently released by ion-exchange with a K 2 CO 3 solution [219] .
As mentioned above, a crucial step in most nucleophilic 18 F-syntheses is the removal of target water from [ 18 F]fluoride. Possibilities to realize this for microfluidic systems are the use of a gas stream conveyed through the capillaries [57, 220] , or the above-mentioned electrochemical methods. On the other hand, since several studies show that some nucleophilic radiofluorination methods are tolerant to protic solvents and even tolerate a small content of water, this helps to simplify the automation of the drying step [73, 221] .
Further, the in-flow purification is a major challenge in microfluidic radiochemistry. Therefore, the use of microanalytic flow separations [222] might be advantageous. A final concentration of the product solution could be performed by solid-phase [223] and also by on-chip solid-phase extraction [224] . A novel method reported the use of sweeping gas membrane distillation, to rapidly perform the concentration and formulation process in a fully automated microfluidic system [225] .
To realize all necessary conditions for radiofluorination by microfluidic devices, two main constructions were designed [209, 211] , the continuous-flow [226, 227] and the stop-flow (batch mode, also called "micro-vessel") [228] microfluidics. A challenge of both systems is the necessity to connect the microfluidic devices to classical lab ware and [188] to combine it with sensors and heating systems [210] . Furthermore, the material of the microfluidics devices has to be resistant against organic solvents and heating [229] . In spite of all those difficulties, several syntheses of clinically relevant 18 [238, 239] , and 7-(6-fluoropyridin-3-yl)-5H-pyrido [4,3-b] indole ([ 18 F]T807) [240] . Last not least, another serious demand with regard to the production by microfluidics is the fulfilment of pharmaceutical regulations [241] . This includes the qualification of starting materials, the in-process control and particularly the quality control of single batch (dose-on-demand) productions [210, 242, 243] .
Advances in quality control procedures
As pointed out already in the context of automatized production methods, old and new procedures and materials must comply with the requirements of a GMP-conform preparation of radiopharmaceuticals and consider their facilitation, including the quality control methods themselves.
Regarding the short half-life of fluorine-18, quality control methods have to be fast and reliable. On the other hand, high-end equipment is not available in many clinics. Therefore, it is desirable that the analytical methods have to be on an easy level. [190, [244] [245] [246] . For radiopharmaceuticals, which have no UV activity, capillary electrophoresis offers itself as an alternative, as well as for the detection of non-radioactive impurities [247] .
The requirements for the quality control of [ 18 F]FDG are set out in the monographs of various pharmacopoeias, like the European or the United States Pharmacopeia, including the appearance of the product solution, radiochemical purity, chemical purity, pH, residual solvent, sterility and bacterial endotoxin levels. The Japanese Pharmacopeia further requires testing the concentration of Al 3+ , which should be limited to 10 ppm per batch. For example, the [
18 F]FDG cassettes for the most used synthesis devices, namely the GE FASTlab, are available with phosphate or citrate buffer. In a two-centre study, it was found out that the phosphate cassettes often show precipitates of aluminium phosphates, formed by the interaction of phosphate buffer with Al 3+ ions eluted from the alumina cartridge, what does not fulfil the requirement of the Japanese Pharmacopeia and also not the requirements for product solution appearance of the other pharmacopoeias [248] . Noteworthy is also the great effort invested to prove the absence of crypt-222 in the final solution of 18 F-radiopharmaceuticals, which is another important quality control criterion. The techniques used include simple TLC [249] [250] [251] [252] , GC [253] , HPLC [245, 252] , and capillary electrophoresis [247] , but also highly sophisticated LC-MS analytics [254] . A novel and simple method makes use of the colour change of I 2 /I − solutions [255] .
Closing remarks
The large number of publications on the development of radiofluorination in recent years, concerning all areas of radiopharmaceutical production for PET imaging, reflects, exemplarily for this field, the innovative level and creativity of radiopharmaceutical sciences. Much success and progress were achieved, providing many improved, modified or even completely new radiofluorination methods, which are considered with respect to their suitability for the clinical supply with 18 F-radiopharmaceuticals. As mentioned above, important aspects comprise, besides effectivity, i.e. activity yield and costs, especially the ease (practicality) of performance (automation) and the reliability of routine application, as well as the compliance of radiopharmaceutical production with GMP requirements. Thus, also compiled here were advances, concerning the automation of radiosyntheses on dedicated cassette and kit systems, or by microfluidics, to facilitate safe routine production, as well as those improving quality control procedures. The impact and requirements of GMP are often underestimated, or even ignored, not only considering routine production, but also during the design and realisation of radiopharmaceuticals. Since radiopharmaceutical chemistry is a very multidisciplinary field, generally performed by radiochemists, the essential pharmaceutical knowledge must be provided by pharmacists or appropriate education, and must also be mentioned here as a concern, as was recently discussed for other possible 'gaps in the pipeline of 18 F-tracer development for PET' [256] . F-labelling of non-activated and especially electron-rich aromatic molecules, in contrast, poses still major challenges. Therefore, a great part of research has recently concentrated on these issues, and very interesting modern fluorination methods have been or are being adapted to the synthesis of n.c.a. [ 18 F]fluoroarenes. Here, some novel approaches with a great potential, facilitating and achieving the production of a still wider variety of 18 F-radiopharmaceuticals, may particularly be pointed out, besides several others. These are all copper-catalysed 18 F-radiofluorinations applicable for electron-rich arenes, using either aryliodonium or stannylated aryl precursors [154, 170] , or aryl boronic esters [171] , whereby both methods find already rapid introduction into the routine production of radiotracers. Furthermore, the very recent, still experimental, but extraordinary "C-H 18 F-fluorination" of (hetero)-arenes is to be mentioned [154, 155, 171] .
The general goal of nearly all novel radiofluorination methods is to save reaction steps, to attain short synthesis times and to facilitate automation. This, however, is often only achieved at the expense of the necessity to synthesise specific precursors and/or that of using different mediating or activating additives. Many of the discussed helpful improvements benefit from modern, potentially toxic metal compounds and catalysts. For that, attention must be paid to the additional complexity to fulfil the requirements of GMP. Quarantine, fast and simple methods for quality control and testing of identity, etc., must be established for each further substance used in the production process. Examples like the aforementioned toxicity of crypt-222 or of transition metals and the, in part difficult to achieve, setup of simple but reliable analytical procedures speak here for themselves.
From the many developments listed in this review, some are still from basic studies and concern principal n.c.a. reactions with simple test compounds, but not yet, or only to a limited extent, their application for production of established or new PET probes. Some published novel methods hold great promise so far, to facilitate production in the future. Others have already proven their advantage and suitability for an automated routine production, while with some such experience does not yet exist, or is only limited to one laboratory. Unfortunately, many studies were performed isolated from each other and thus, are not directly comparable to similar approaches, which often depend on specific local resources (conditions and equipment) and clinical demands.
In [137] . The latter is one of the few examples, where several labelling strategies were pursued with much effort and realised over the last three decades.
Indeed, many more comparative evaluations under practical conditions of routine production and with comparable efforts are desirable, preferentially confirmed, or in collaboration, by various centres.
As the example of 6-[ 18 F]FDOPA shows, there might be various options to select from established or rather new procedures in the literature, when newly setting up a synthetic procedure of an established radiopharmaceutical. However, if an existing process is supposed to be changed to a newer one, the additional value has to justify the operating expenses under ecological and technological aspects, including all steps of production, from nuclide production and required reagents, via automated synthesis to formulation and quality control. All this must fit to the general conditions, including clinical demands, e.g. frequency of production, and the philosophy of the laboratory.
Given the multitude of present approaches and their developmental stages, reflecting in part also different strategies, it seems presently too early for final judgements or recommendations on the clinical usefulness of all these methods. Considering, however, the very many promising developments going on and the obvious high potential of radiopharmaceutical scientists, there is great confidence in further inventions and the establishment of a standardised methodology for reliable routine production. For example, the use of modern, high-resolution mass spectrometry in combination with minute amounts of fluorine-19 reagents, as recently realised [257] , bears the potential to considerably accelerate studies on n.c.a. 18 F-fluorination reactions without application of the radioactive isotope. Thus, improved radiofluorination and production processes, together with advancing smart and specific 18 F-radiopharmaceuticals, will ensure the extension of in vivo molecular imaging with positron-emission tomography and serve in a symbiotic collaboration with nuclear medicine to promote research on diseases and to improve diagnostics of patients. 
